Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Phenobarbital 3.24 mg/ml/Belladonna Leaf Alkaloids 0.025 mg/ml Oral Suspension is a compounded formulation designed to treat conditions such as epilepsy, anxiety, insomnia, seizures, and hysteria. This medication is a liquid dosage form, ensuring a uniform dispersion of ingredients for effective administration.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specially compounded oral suspension formulation of Phenobarbital 3.24 mg/ml and Belladonna Leaf Alkaloids 0.025 mg/ml. This unique formulation is designed to address a range of disease states, including seizures, spasms, and cramps. The synergistic effect of these two active ingredients allows for a more potent treatment than if either ingredient were used independently.
Phenobarbital, a barbiturate, functions as a sedative and anticonvulsant. On the other hand, Belladonna Leaf Alkaloids are anticholinergic agents that can help alleviate spasms and cramps. The combination of these two ingredients in this formulation enhances the overall effectiveness of the treatment.
This formulation is provided in an oral suspension form, a liquid dosage form in which one or more ingredients are dispersed uniformly throughout a liquid medium. This ensures a homogeneous mixture for administration, making it easier to administer and more palatable for patients. It is crucial to note that this formulation should only be used under the direct supervision of a healthcare professional.
If you have any inquiries about this formulation or wish to understand more about how it can help treat your patients' disease states, please do not hesitate to contact us at Bayview Pharmacy. We are committed to assisting you in finding the most suitable treatment options for your patients.
This compounded formulation of Phenobarbital 3.24 mg/ml and Belladonna Leaf Alkaloids 0.025 mg/ml in an Oral Suspension is specifically designed for the treatment of seizures, spasms, and other conditions associated with the central nervous system. It is crucial to understand that this formulation is contraindicated in patients with known hypersensitivity to either Phenobarbital or Belladonna Leaf Alkaloids. Furthermore, it should not be administered to patients with severe liver or kidney disease due to the potential increase in the risk of adverse effects.
Patients are strongly advised to abstain from alcohol while on this medication as it may exacerbate the risk of adverse effects. Regular monitoring for signs of sedation, confusion, and other CNS-related adverse effects is necessary. If any of these effects are observed, the dose may need to be adjusted accordingly. Similarly, patients should be monitored for signs of anticholinergic effects, such as dry mouth, blurred vision, and constipation. If these effects occur, dose adjustment may be necessary.
Caution is advised when using this formulation in patients with a history of glaucoma, as it may increase the risk of intraocular pressure. Similarly, it should be used with caution in patients with a history of urinary retention, as it may exacerbate this condition. If you have any questions or concerns about this formulation or its use, please do not hesitate to reach out for further information.
Phenobarbital 3.24 mg/ml/Belladonna Leaf Alkaloids 0.025 mg/ml Oral Suspension is a compounded formulation that combines two potent medications, Phenobarbital and Belladonna Leaf Alkaloids, to treat a variety of conditions. Phenobarbital, an anticonvulsant, is primarily used to manage and reduce the frequency of seizures.
This unique combination of medications is particularly beneficial in managing conditions such as irritable bowel syndrome, urinary incontinence, and biliary colic. When administered orally, both Phenobarbital and Belladonna Leaf Alkaloids are absorbed into the bloodstream and distributed throughout the body. The Phenobarbital component works by reducing the severity and frequency of seizures, while the Belladonna Leaf Alkaloids work by relaxing the muscles in the gastrointestinal, urinary, and biliary tracts. This dual action helps to alleviate spasms and improve symptoms associated with the aforementioned conditions.
It is crucial to adhere to the prescribed dosage when taking this medication. Overdosing or underdosing can lead to undesirable effects or reduced efficacy. To minimize the risk of stomach upset, it is recommended to take this medication with food or a full glass of water. Side effects such as nausea, vomiting, or dizziness should be reported to your doctor immediately.
If you have any queries about this compounded formulation or its mechanism of action, do not hesitate to ask. It is our responsibility to ensure you are well-informed about your treatment options and how they work.
This compounded formulation of Phenobarbital 3.24 mg/ml and Belladonna Leaf Alkaloids 0.025 mg/ml is presented in an oral suspension. This means that the active ingredients are uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture for administration. This formulation is versatile and may be used to treat a variety of conditions.
It can be used in the management of spasticity, tetanus, and alcohol withdrawal. It may also serve as a preoperative sedative, helping to alleviate anxiety and tension before surgery. Furthermore, it can be used to manage symptoms of Parkinson’s disease, such as tremors, rigidity, and difficulty with movement.
However, it is crucial to note that this formulation is contraindicated in patients with glaucoma, myasthenia gravis, or a history of depression. It is also important to be aware of potential side effects, which may include drowsiness, dizziness, and blurred vision.
As with any medication, it is essential to use this formulation under the guidance of a healthcare professional. If you have any questions or concerns about the use of this formulation, please consult with your healthcare provider.
This is a compounded formulation that combines Phenobarbital and Belladonna Leaf Alkaloids in a liquid dosage form. The ingredients are uniformly dispersed throughout a liquid medium, providing a homogeneous mixture for administration.
This formulation is typically used for its sedative and antispasmodic properties. Phenobarbital is a barbiturate, often used to treat seizures, while Belladonna Leaf Alkaloids are used to treat various gastrointestinal disorders.
This medication should be stored at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This medication is taken orally. The dosage is dependent on the patient's medical condition and response to therapy. It is important to take this medication exactly as prescribed by your healthcare provider.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Side effects may include drowsiness, dizziness, constipation, or dry mouth. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Consult your healthcare provider before taking this medication if you are pregnant or breastfeeding. The effects on the unborn baby or nursing infant are not fully known.
Alcohol may increase the sedative effects of this medication and should be avoided. Always consult your healthcare provider for more information.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Symptoms of overdose may include severe drowsiness, slow or shallow breathing, severe dizziness, or inability to wake up.
Before starting this medication, tell your doctor or pharmacist of all the products you use, including prescription drugs, nonprescription drugs, and herbal products. They can check for any potential drug interactions.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
